Ischemic heart disease Board decisions

The appeals for an effective date prior to June 28, 2023 for the grant of service connection for coronary artery disease, a disability rating higher than 30 percent for coronary artery disease, and a compensable disability rating for hypertension were dismissed due to duplicate claims in the system.

The Board remands the issues of entitlement to an initial rating in excess of 10 percent prior to January 25, 2016, in excess of 30 percent from January 25, 2016, to January 21, 2020, and in excess of 60 percent thereafter for coronary artery disease, myocardial infarction, and PTCA (CAD) and entitlement to a total disability rating based upon individual unemployability due to service-connected disabilities (TDIU) prior to August 10, 2022, as the case requires additional development.

The Board remands the claims for service connection due to a lack of complete Reserve service records and unclear in-service toxic exposures.

The Board remands the claims for a retrospective medical opinion addressing the severity of the Veteran's CAD prior to January 18, 2024, and TDIU.

The Board granted an initial 60 percent rating for hypertensive heart disease, a separate 10 percent rating for hypothyroidism residuals, urinary symptoms, and a separate 10 percent rating for hypothyroidism residuals, gastrointestinal symptoms. A 20 percent rating was also granted for dry eye syndrome and pseudophakia due to cataract extraction, associated with hypothyroidism.

The Veteran's PTSD was granted a 50% rating from September 27, 2021 to March 8, 2023; however, ratings in excess of 50% and 70% were denied. The claims for earlier effective dates for service connection for coronary artery disease, left lower extremity diabetic peripheral neuropathy, and right lower extremity diabetic peripheral neuropathy were also denied.

The Board denied service connection for PTSD, asthma, stomach pains, a heart disability secondary to PTSD, and non-compensable ratings for allergic rhinitis and bilateral hearing loss.

The appeals for service connection for coronary artery disease and aortic stenosis were dismissed as they are pending under the Legacy docket.

The Board remands the claims for service connection due to a pre-decisional duty to assist error regarding herbicide agent exposure.

The Board denied the Veteran's claims for an earlier effective date prior to August 10, 2022, for service connection for coronary artery disease and diabetes mellitus type II, as these conditions are subject to the PACT Act's effective date.

The Board granted earlier effective dates for the award of service connection for arteriosclerotic heart disease and polyneuropathy, as well as special monthly compensation based on housebound criteria.

The Board remands the claims for service connection for bilateral hearing loss and heart disease disabilities to correct an error by the AOJ, ensuring that any evidence not considered will be addressed in a re-adjudication.

The Board granted service connection for coronary artery disease as secondary to the Veteran's service-connected obstructive sleep apnea disability.

The Board denied service connection for a heart condition due to the lack of evidence showing a current diagnosis or residuals, and remanded claims for hypertension and prostate cancer for further development.

The Board granted an effective date of February 12, 2023, for the award of service connection for coronary artery disease based on the Blue Water Navy Vietnam Veterans Act of 2019.

The Veteran withdrew his appeal for service connection for liver disability, ischemic heart disease, diabetes mellitus, and benign prostatic hyperplasia.

The Board denied service connection for a heart disability, to include atrial fibrillation, myocardial infarction/ischemic heart disease, cardiomyopathy, and congestive heart failure, as the evidence did not show that the Veteran's current heart condition was related to his active military service.

The Board denied a rating in excess of 30 percent for coronary artery disease and remanded the claim for interstitial lung disease due to an inadequate VA examination.

The Board remands the claim for service connection for heart disease, to include coronary artery disease, as it requires a VA examination with an opinion addressing whether the Veteran's heart condition is proximately caused by or aggravated by any of his service-connected disabilities.

The Board remands the claims for service connection for type two diabetes mellitus, heart condition, and prostate cancer to obtain a medical examination addressing the nature and etiology of the Veteran's claimed conditions.